SmartVascular Dx

We believe the current standard of care fails to accurately detect vascular disease.

• Heart disease is the leading cause of death in the US and for most people, the first sign of heart disease is a heart attack.
• 70% of heart attacks are caused by unstable cardiac lesion ruptures.
• When the lesions become inflamed, they are prone to rupture causing a blood clot which blocks blood flow to the heart resulting in a heart attack.
• 80% of premature deaths due to vascular disease are preventable with early diagnosis, management of risk factors, and lifestyle modification.

Advantages of SmartVascular Dx:

• A serum blood test we believe detects the risk of potential heart attacks and strokes of a vulnerable patient within the next 5 years.
• This diagnostic test assesses vascular health by measuring protein biomarkers that indicate inflammation in arterial lining that can lead to heart attacks and strokes.
• The test was developed through a series of longitudinal outcome-based studies with multiple institutions over a 15-year period of collaborative research representing over 40,000 patients.
• SmartVascular Dx was independently validated at the National Institute of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) in the Multi-Ethnic Study of Atherosclerosis (MESA).